Researchers at UCSF and UCLA created an AI algorithm to analyze health records, identify patterns and flag potential AHP patients, aiming to enhance diagnosis of rare diseases.
A phase II trial for patients with traumatic brain injury (TBI) will aim to break the impasse of 30 years of failed clinical trials for TBI. The study will compare the effects of off-label drugs that have been found to be effective in animal studies.
An off-the-shelf drug developed for smallpox, a cousin of mpox, proved safe for mpox patients but ineffective at curing the disease. But the clinical trial itself, launched rapidly as cases spread in 2022, could be a model for similar current and future epidemics.
UCSF researchers have found clues about how frontotemporal dementia develops that could lead to new diagnostics and get more patients into clinical trials.
Five emerging UCSF leaders envision a future of innovative health and science. They aim to address health disparities, improve patient care, and advance scientific research through technology and policy.
In pancreatic cancer, metastasis is often the first sign that a patient even has cancer, and by then, the cancer has spread out of control. Researchers discovered how pancreatic cancer cells migrate to other organs, where they become dangerous enough to kill.
Neuro-immunologist Stephen Hauser, MD, whose maverick thinking transformed the treatment landscape for patients with multiple sclerosis (MS), has received the 2025 Breakthrough Prize in Life Sciences.
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UC San Francisco has found.
To help patients recover more quickly, hospitals may provide physical and occupational therapy – especially for older adults to help them preserve or regain function. How much therapy is best, though, isn’t clear.
A new all-electric ferry to Mission Bay launches in 2027, supported by a $55M EPA grant, aiding UCSF commuters and patients.
